Search the Newsreel

Comstock Holding Companies Inc. (CHCI) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live stock quotes and charts for Comstock Holding Companies Inc. (CHCI) from NASDAQ, showing a stock price of $15.10 with a daily gain of 1.89%. It notes that there is no analyst rating or earnings information currently available for CHCI. The …

Armstrong World Industries, Inc. Revenue Breakdown – XETR:91A

Armstrong World Industries, Inc. (XETR:91A) generated 1.38 billion EUR in revenue last year. The Mineral Fiber segment was the top-performing segment, contributing 877.56 million EUR, and the United States was the largest regional contributor with 1.30 billion EUR.

NewAmsterdam Pharma: Obicetrapib Is More Than Another LDL-Lowering Pill

NewAmsterdam Pharma Stock: Obicetrapib More Than Another LDL-Lowering Pill (NASDAQ:NAMS)

How EMA’s Positive CHMP Opinion on Ubeslo and Evlarco at NewAmsterdam Pharma (NAMS) Has Changed Its Investment Story

NewAmsterdam Pharma (NAMS) received a positive CHMP opinion from the EMA for its drugs Ubeslo and Evlarco, recommending EU-wide marketing authorization for primary hypercholesterolemia. This development validates the clinical program and brings the company closer to royalty and milestone economics in Europe through its …

SEB Asset Management AB Purchases New Shares in HA Sustainable Infrastructure Capital, Inc. $HASI

SEB Asset Management AB initiated a new position in HA Sustainable Infrastructure Capital, Inc. (NYSE:HASI) by purchasing 32,900 shares valued at approximately $1.21 million in the first quarter. This investment follows HASI's strong Q1 earnings, which surpassed analyst estimates, and the company's declaration of …

Comstock Holding Companies, Inc. Revenue Breakdown – NASDAQ:CHCI

CRK|Comstock Resources Inc|Price:13.520|Chg%:-0.190

Comstock Resources Inc (CRK) is an independent energy company focused on oil and natural gas exploration and production in the Haynesville shale. The company shows high growth in revenue and profit, considered fairly valued with a strong institutional ownership. Despite recent stock market underperformance, …

Armstrong World Industries’ Bigger Buyback and Steady Dividend Might Change The Case For Investing In AWI

Armstrong World Industries has affirmed a steady quarterly dividend and significantly increased its share repurchase authorization, signaling a strong focus on returning cash to shareholders. While the company's investment narrative remains tied to commercial construction cycles, these actions aim to boost per-share metrics and …

HA Sustainable Infrastructure Capital, Inc. Revenue Breakdown – NYSE:HASI

CHMP backs NewAmsterdam Pharma (Nasdaq: NAMS) cholesterol therapies for EU approval

NewAmsterdam Pharma (Nasdaq: NAMS) has received a positive opinion from the European Medicines Agency's CHMP for its cholesterol therapies, Ubeslo (obicetrapib monotherapy) and Evlarco (obicetrapib plus ezetimibe fixed-dose combination). This recommendation, based on strong Phase 3 clinical trial data showing significant LDL-C reductions, is …

Europe's drug committee recommends two NewAmsterdam cholesterol treatments

NewAmsterdam Pharma and Menarini Group received a positive opinion from the European Medicines Agency's CHMP recommending EU marketing authorization for two cholesterol-lowering treatments, Ubeslo (obicetrapib monotherapy) and Evlarco (obicetrapib plus ezetimibe fixed-dose combination). This recommendation is based on positive Phase 3 clinical trial data …

NewAmsterdam Pharma gets positive CHMP opinion for obicetrapib-based Ubeslo and Evlarco, EC decision due 2H26

NewAmsterdam Pharma (NAMS) received a positive CHMP opinion recommending EU marketing authorization for its cholesterol-lowering drugs, Ubeslo (obicetrapib 10 mg) and Evlarco (obicetrapib 10 mg + ezetimibe 10 mg). The recommendation is based on strong Phase 3 trial data showing significant LDL-C reductions. A …

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

NewAmsterdam Pharma and Menarini Group announced that the CHMP has recommended marketing authorization for Ubeslo® (obicetrapib monotherapy) and Evlarco® (obicetrapib plus ezetimibe fixed-dose combination) for patients with primary hypercholesterolemia. This positive opinion targets a major unmet need for patients unable to reach LDL-C goals …

How Hannon Armstrong Sustainable Infrastructure Capital Inc. (HASI) Affects Rotational Strategy Timing

This article analyzes how Hannon Armstrong Sustainable Infrastructure Capital Inc. (HASI) influences rotational strategy timing, identifying weak near-term sentiment but strong long-term potential. It provides AI-generated trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss zones. The analysis also includes …

Armstrong World to Post Q2 Earnings: What's in Store for the Stock?

Armstrong World Industries (AWI) is set to report its second-quarter 2026 results on July 28, with expectations of 11.5% year-over-year EPS growth and an 8% increase in revenues, driven by commercial renovation demand, Architectural Specialties momentum, and recent acquisitions. The company's earnings model does …

Comstock Resources: A Leveraged Call On The Gulf Coast Natural Gas Bottleneck

This article analyzes Comstock Resources (NYSE: CRK) as a "Buy" opportunity, viewing it as a leveraged play on an anticipated tightening natural gas market in the Gulf Coast. The author argues that while CRK carries significant debt and negative current free cash flow, its …

ABN Amro Investment Solutions Increases Holdings in HA Sustainable Infrastructure Capital, Inc. $HASI

ABN Amro Investment Solutions significantly increased its stake in HA Sustainable Infrastructure Capital (HASI) by 29.7% in the first quarter, now holding 225,941 shares valued at approximately $8.3 million. This increase follows a strong financial quarter for HASI, which surpassed EPS and revenue estimates …

Comstock Holding Companies (CHCI) Proxy Filing Summary

Comstock Holding Companies (CHCI) has released a proxy filing summary detailing the agenda for its annual meeting on June 11, 2025. Key proposals include the election of directors, ratification of Grant Thornton LLP as auditor, advisory votes on executive compensation, and the adoption of …

NewAmsterdam Pharma Company (NAMS) Q1 2026 earnings summary

NewAmsterdam Pharma (NAMS) released its Q1 2026 earnings summary, highlighting its focus on obicetrapib, a CETP inhibitor for LDL-C lowering, with regulatory decisions expected in 2H26. Financials showed $3.0 million in revenue, a net loss of $48.4 million, and $707.3 million in cash reserves. …

Enterprise value to revenue forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS

The article provides financial information for NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), focusing on its enterprise value to revenue forward metric. It appears to be a stub or partial financial data page from TradingView, offering a glimpse into the company's valuation. The content highlights …

Armstrong World Industries Inc (AWI) Stock Up 3.9% and Still Undervalued -- GF Score: 84/100

Armstrong World Industries Inc (AWI) saw its stock rise by 3.9% on July 22, 2026, reaching $157.28, and GuruFocus assessed it as undervalued with a GF Value™ of $168.92. The company holds a strong GF Score™ of 84/100, particularly excelling in Valuation and Profitability, …

NewAmsterdam Pharma's COO Douglas Kling to Leave for CEO Role at Another Clinical-Stage Biotech Company

Douglas Kling, COO of NewAmsterdam Pharma, has announced his resignation effective August 14, 2026, to become CEO at another clinical-stage biotechnology company. The company anticipates negotiating a separation and an advisor agreement with Kling to ensure a smooth transition, particularly for the PREVAIL clinical …

NewAmsterdam Pharma (NAMS) CAO trades 105000 shares under 10b5-1 plan

NewAmsterdam Pharma Co N.V.'s Chief Accounting Officer, Louise Frederika Kooij, exercised options for 105,000 ordinary shares and subsequently sold all of them on July 20, 2026. These transactions, executed under a Rule 10b5-1 trading plan adopted on February 23, 2026, involved weighted average prices …

NewAmsterdam Pharma (NAMS) COO Douglas Kling to step down Aug 14

NewAmsterdam Pharma Company N.V. announced that its Chief Operating Officer, Douglas Kling, will resign effective August 14, 2026, to become CEO of another clinical-stage biotech company. Kling notified the company of his decision on July 16, 2026. NewAmsterdam Pharma expects to enter into a …

Armstrong World Industries declares BRL 1.16 per unit distribution for Q3 2026

Armstrong World Industries announced a third-quarter 2026 distribution of BRL 1.16 per unit (ISIN BRAWIIBDR009). The last day to trade with entitlement is August 3, 2026, with the payment date scheduled for August 25, 2026. This news brief was generated by Public Technologies using …

HASI stock holds after latest report and dividend update

Hannon Armstrong Sustainable Infrastructure Capital, Inc. (HASI) maintains a $1.2 billion market capitalization as of July 22, 2026, with 2025 revenue of $104.2 million and net income of $56.8 million. The company reported a Q2 2026 dividend of $0.42 per share, reflecting significant year-over-year …

Jennison Associates LLC Cuts Stock Position in NewAmsterdam Pharma Company N.V. $NAMS

Jennison Associates LLC reduced its stake in NewAmsterdam Pharma Company N.V. by 21.2% in the first quarter of 2026, selling 738,818 shares and retaining 2.75 million shares valued at $88 million. Despite this reduction, institutional ownership remains high at 89.89%, with several other firms …

Analysts Estimate Comstock Resources (CRK) to Report a Decline in Earnings: What to Look Out for

Analysts expect Comstock Resources (CRK) to report a significant year-over-year decline in earnings and lower revenues for the quarter ended June 2026, with an estimated EPS of $0.02, down 84.6%, and revenues of $415.15 million, down 11.7%. The consensus EPS estimate has been revised …

Armstrong World Industries stock trades steadily as ceiling specialist leans on margin strength and

Armstrong World Industries (AWI) stock is supported by its focused strategy on high-margin mineral fiber ceilings, recent pricing gains, and returning cash to shareholders. The company operates in the non-residential construction and renovation market, emphasizing margin improvement through productivity and targeted price increases. Investors …

Siebert Williams Shank Maintains Comstock Resources(CRK.US) With Hold Rating, Maintains Target Price $16

Siebert Williams Shank has reiterated its Hold rating on Comstock Resources (CRK.US), keeping the target price at $16. This indicates the firm's continued neutral stance on the stock's future performance.

Comstock Resources (CRK) Projected to Post Earnings on Wednesday

Comstock Resources (CRK) is anticipated to announce its Q2 2026 earnings on Wednesday, July 29th, with analysts forecasting a $0.02 EPS on $418.9 million in revenue. The company missed EPS estimates in the prior quarter but exceeded revenue forecasts with a 14.5% year-over-year increase. …

NewAmsterdam Pharma Company (NAMS) Citi Annual Global Healthcare Conference 2025 summary

This summary of NewAmsterdam Pharma's presentation at the Citi Annual Global Healthcare Conference 2025 highlights obicetrapib's strong LDL lowering, Lp(a) reduction, and potential benefits in diabetes risk and Alzheimer's prevention, supported by positive phase 3 trial results. The drug aims to be a primary …

Armstrong World Industries increases buyback authorization by $800M

Armstrong World Industries (NYSE: AWI) has announced an additional $800 million authorization for its share repurchase program, increasing the total to $2.5 billion and extending it through December 31, 2029. The company's Board of Directors also declared a cash dividend of $0.339 per share, …

Press Release: Armstrong World Industries Announces Increase to Share Repurchase Program and Quarterly Dividend

Armstrong World Industries has announced an increase to its share repurchase program, raising the total authorization to $500 million. The company also declared a quarterly cash dividend of $0.18 per share, payable on August 16, 2024, to shareholders of record as of August 2, …

Armstrong World Industries boosts buyback by $800M, raises program to $2.5B and declares $0.339 dividend

Armstrong World Industries has approved an $800 million increase to its share repurchase authorization, bringing the total program to $2.5 billion, and extended it through December 31, 2029. The company also declared a quarterly cash dividend of $0.339 per share, payable on August 19, …